Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 15, 2002 08:26 ET | Source: Pharmexa A/S

Pharmexa In-Licenses Formulation Technology from ZYCOS for the AutoVac HER-2 DNA Therapeutic Cancer Vaccine

HORSHOLM, Denmark, May 15, 2002 (PRIMEZONE) -- Pharmexa and ZYCOS today jointly announced that they have entered into an agreement to formulate Pharmexa's therapeutic DNA breast cancer vaccine in...
November 26, 2001 04:27 ET | Source: Noonan/Russo Ltd.

GPC Biotech Signs Agreement with ICOS to Manufacture Antibodies for Clinical Studies (with link)

MARTINSRIED/MUNICH, Germany and BOSTON, Nov. 26, 2001 (PRIMEZONE) -- GPC Biotech AG (Frankfurt Stock Exchange:GPC) announced the signing of a development and manufacturing agreement with ICOS...